Erasca (ERAS) Net Cash Flow (2020 - 2026)
Erasca (ERAS) posted Net Cash Flow of -$26.5 million for Q1 2026, down 842.63% on a QoQ basis from $3.6 million in Q4 2025, and down 1067.88% year-over-year from $2.7 million in Q1 2025.
Erasca (ERAS) Net Cash Flow (2020 - 2026) Analysis & Trends
Erasca's Net Cash Flow history runs 7 years deep, the most recent figure standing at -$26.5 million for Q1 2026.
- Quarterly Net Cash Flow fell 1067.88% year-over-year to -$26.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.2 million (down 271.97% YoY) and the FY2025 annual result came in at $6.1 million, up 123.94% from the prior year.
- Net Cash Flow was -$26.5 million for Q1 2026 at Erasca, down from $3.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $96.1 million in Q2 2024 and bottomed at -$134.0 million in Q2 2023.
- A 5-year average of -$18.4 million and a median of -$16.3 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2025 — Net Cash Flow soared 411.95% — and 2026, when it tumbled 1067.88%.
- Erasca's Net Cash Flow stood at $65.0 million in 2022, then plunged by 130.46% to -$19.8 million in 2023, then soared by 94.21% to -$1.1 million in 2024, then surged by 411.95% to $3.6 million in 2025, then slumped by 842.63% to -$26.5 million in 2026.
- Business Quant data shows ERAS's Net Cash Flow at -$26.5 million in Q1 2026, $3.6 million in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | -26.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.55 Mn |
| Mar 31, 2026 | -26.55 Mn |
| Dec 31, 2025 | 3.58 Mn |
| Dec 31, 2025 | 3.58 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | -4.34 Mn |
| Jun 30, 2025 | -4.34 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Sep 30, 2024 | -103.92 Mn |
| Sep 30, 2024 | -103.92 Mn |
| Jun 30, 2024 | 96.08 Mn |
| Jun 30, 2024 | 96.08 Mn |
| Mar 31, 2024 | -16.35 Mn |
| Mar 31, 2024 | -16.35 Mn |
| Dec 31, 2023 | -19.79 Mn |
| Dec 31, 2023 | -19.79 Mn |